Hyaluronic Acid, Spleen Size and Prothrombin Time Predict the Existence of High-Risk Esophageal Varices in Non-Viral Cirrhosis in Real Life

1. Trusheim, M.R., E.R. Berndt, and F.L. Douglas, Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov, 2007. 6(4): p. 287-93.10.1038/nrd225117380152Search in Google Scholar

2. Stein, G., Long-term therapy of chronic cor pulmonale. Dtsch Med Wochenschr, 1967. 92(42): p. 1922-4.10.1055/s-0028-11060676047908Search in Google Scholar

3. Augustin, S., et al., Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology, 2017. 66(6): p. 1980-1988.10.1002/hep.2936328696510Search in Google Scholar

4. El-Serag, H.B. and J.E. Everhart, Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol, 2000. 95(12): p. 3566-73.10.1111/j.1572-0241.2000.03376.x11151893Search in Google Scholar

5. Carbonell, N., et al., Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology, 2004. 40(3): p. 652-9.10.1002/hep.2033915349904Search in Google Scholar

6. Garcia-Tsao, G., et al., Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol, 2007. 102(9): p. 2086-102.10.1111/j.1572-0241.2007.01481.x17727436Search in Google Scholar

7. Vallet-Pichard, A., et al., FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology, 2007. 46(1): p. 32-6.10.1002/hep.2166917567829Search in Google Scholar

8. Wai, C.T., et al., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003. 38(2): p. 518-26.10.1053/jhep.2003.5034612883497Search in Google Scholar

9. de Franchis, R. and V.I.F. Baveno, Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol, 2015. 63(3): p. 743-52.10.1016/j.jhep.2015.05.02226047908Search in Google Scholar

10. Adams, L.A., et al., Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem, 2005. 51(10): p. 1867-73.10.1373/clinchem.2005.04838916055434Search in Google Scholar

11. Kalantari, H., et al., Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection. Hepat Res Treat, 2011. 2011: p. 972759.10.1155/2011/972759Search in Google Scholar

12. Wiesner, R., et al., Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology, 2003. 124(1): p. 91-6.10.1053/gast.2003.50016Search in Google Scholar

13. Child, C.G. and J.G. Turcotte, Surgery and portal hypertension. Major Probl Clin Surg, 1964. 1: p. 1-85.Search in Google Scholar

14. Pugh, R.N., et al., Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973. 60(8): p. 646-9.10.1002/bjs.1800600817Search in Google Scholar

15. Charlson, M.E., et al., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987. 40(5): p. 373-83.10.1016/0021-9681(87)90171-8Search in Google Scholar

16. Forns, X., et al., Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, 2002. 36(4 Pt 1): p. 986-92.10.1016/S0270-9139(02)00107-6Search in Google Scholar

17. Pang, J.X., et al., The feasibility and reliability of transient elastography using Fibroscan(R): a practice audit of 2335 examinations. Can J Gastroenterol Hepatol, 2014. 28(3): p. 143-9.10.1155/2014/952684407188324619636Search in Google Scholar

18. Mitchell, O., et al., The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med, 2016. 8: p. 39-50.10.2147/HMER.S74612Search in Google Scholar

19. Lindenbaum, J. and C.S. Lieber, Hematologic effects of alcohol in man in the absence of nutritional deficiency. N Engl J Med, 1969. 281(7): p. 333-8.10.1056/NEJM1969081428107015794307Search in Google Scholar

20. Cowan, D.H. and J.D. Hines, Thrombocytopenia of severe alcoholism. Ann Intern Med, 1971. 74(1): p. 37-43.10.7326/0003-4819-74-1-375539275Search in Google Scholar

21. Fontana, R.J., et al., Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology, 2010. 138(7): p. 2321-31, 2331 e1-2.10.1053/j.gastro.2010.02.058Search in Google Scholar

22. Thachil, J., Relevance of clotting tests in liver disease. Postgrad Med J, 2008. 84(990): p. 177-81.10.1136/pgmj.2007.06641518424573Search in Google Scholar

23. Schepis, F., et al., Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology, 2001. 33(2): p. 333-8.10.1053/jhep.2001.21410Search in Google Scholar

24. Davis, J.R., et al., Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteers. Am J Trop Med Hyg, 1989. 40(2): p. 128-30.10.4269/ajtmh.1989.40.1282645802Search in Google Scholar

25. Islam, M.N., et al., Plasma Prothrombin Time and Esophageal Varices in Patients with Cirrhosis of Liver. Euroasian J Hepatogastroenterol, 2016. 6(1): p. 10-12.10.5005/jp-journals-10018-1158Search in Google Scholar

26. Colli, A., et al., Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev, 2017. 4: p. CD008759.10.1002/14651858.CD008759.pub2647827628444987Search in Google Scholar

27. Karatzas, A., et al., Nuon-invasive screening for esophageal varices in patients with liver cirrhosis. Ann Gastroenterol, 2018. 31(3): p. 305-314.10.20524/aog.2018.0241Search in Google Scholar